{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:50:59Z","timestamp":1791521459903,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017467","name":"Amplyx","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017467","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.metabol.2026.156773","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:55:16Z","timestamp":1789494916000},"page":"156773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Efficacy and safety of avexitide for treatment of hypoglycemia following bariatric and other upper gastrointestinal surgeries: a phase 2b study"],"prefix":"10.1016","volume":"184","author":[{"given":"Colleen","family":"Craig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Termeh","family":"Shamloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia","family":"Perelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2026.156773_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.soard.2026.03.013","article-title":"Prevalence of post-bariatric hypoglycemia in the United States","author":"Craig","year":"2026","journal-title":"Surg Obes Relat Dis"},{"issue":"6","key":"10.1016\/j.metabol.2026.156773_bb0010","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/bjs.11118","article-title":"Changes in gut hormones, glycaemic response and symptoms after oesophagectomy","volume":"106","author":"Elliott","year":"2019","journal-title":"Br J Surg"},{"issue":"6","key":"10.1016\/j.metabol.2026.156773_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.01.047","article-title":"Important role of the GLP-1 axis for glucose homeostasis after bariatric surgery","volume":"26","author":"Larraufie","year":"2019","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.metabol.2026.156773_bb0020","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000442155","article-title":"Postprandial hypoglycemia in children after gastric surgery: clinical characterization and pathophysiology","volume":"85","author":"Calabria","year":"2016","journal-title":"Horm Res Paediatr"},{"issue":"4","key":"10.1016\/j.metabol.2026.156773_bb0025","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s11695-011-0581-0","article-title":"Acarbose improves hypoglycaemia following gastric bypass surgery without increasing glucagon-like peptide 1 levels","volume":"22","author":"Valderas","year":"2012","journal-title":"Obes Surg"},{"issue":"9","key":"10.1016\/j.metabol.2026.156773_bb0030","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1111\/dom.13796","article-title":"Postprandial hypoglycaemia after Roux-en-Y gastric bypass and the effects of acarbose, sitagliptin, verapamil, liraglutide and pasireotide","volume":"21","author":"\u00d8hrstr\u00f8m","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.metabol.2026.156773_bb0035","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/j.soard.2011.05.010","article-title":"Use of diazoxide in management of severe postprandial hypoglycemia in patient after Roux-en-Y gastric bypass","volume":"9","author":"Gonzalez-Gonzalez","year":"2013","journal-title":"Surg Obes Relat Dis"},{"issue":"12","key":"10.1016\/j.metabol.2026.156773_bb0040","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1007\/s11695-008-9569-9","article-title":"Post-prandial hypoglycemia after bariatric surgery: pharmacological treatment with verapamil and acarbose","volume":"18","author":"Moreira","year":"2008","journal-title":"Obes Surg"},{"issue":"Suppl. 1","key":"10.1016\/j.metabol.2026.156773_bb0045","article-title":"1363-P: Glucagon-like peptide 1 receptor agonists slow gastric emptying but do not prevent hypoglycemia in patients with post-bariatric hypoglycemia [abstract]","volume":"75","author":"Turk","year":"2026","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.metabol.2026.156773_bb0050","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1053\/j.gastro.2013.11.044","article-title":"Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass","volume":"146","author":"Salehi","year":"2014","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.metabol.2026.156773_bb0055","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00125-016-4179-x","article-title":"Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia","volume":"60","author":"Craig","year":"2017","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.metabol.2026.156773_bb0060","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/dom.13078","article-title":"Efficacy and pharmacokinetics of subcutaneous exendin (9-39) in patients with post-bariatric hypoglycaemia","volume":"20","author":"Craig","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"10.1016\/j.metabol.2026.156773_bb0065","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/dom.14048","article-title":"Safety, efficacy and pharmacokinetics of repeat subcutaneous dosing of avexitide (exendin 9-39) for treatment of post-bariatric hypoglycaemia","volume":"22","author":"Tan","year":"2020","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"10.1016\/j.metabol.2026.156773_bb0070","doi-asserted-by":"crossref","first-page":"e3235","DOI":"10.1210\/clinem\/dgab103","article-title":"PREVENT: a randomized, placebo-controlled crossover trial of avexitide for treatment of postbariatric hypoglycemia","volume":"106","author":"Craig","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.metabol.2026.156773_bb0075","doi-asserted-by":"crossref","first-page":"336","DOI":"10.2337\/db22-0568","article-title":"The importance of endogenously secreted GLP-1 and GIP for postprandial glucose tolerance and \u03b2-cell function after Roux-en-Y gastric bypass and sleeve gastrectomy surgery","volume":"72","author":"Hinds\u00f8","year":"2023","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2026.156773_bb0080","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.molmet.2019.12.011","article-title":"Continuous glucose monitoring reveals glycemic variability and hypoglycemia after vertical sleeve gastrectomy in rats","volume":"32","author":"Evers","year":"2020","journal-title":"Mol Metab"},{"issue":"11","key":"10.1016\/j.metabol.2026.156773_bb0085","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1016\/S0021-9258(18)42531-8","article-title":"Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas","volume":"267","author":"Eng","year":"1992","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.metabol.2026.156773_bb0090","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.soard.2021.06.013","article-title":"Defining clinically important hypoglycemia in patients with postbariatric hypoglycemia","volume":"17","author":"Craig","year":"2021","journal-title":"Surg Obes Relat Dis"},{"issue":"1","key":"10.1016\/j.metabol.2026.156773_bb0095","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2337\/dc16-2215","article-title":"Glucose concentrations of less than 3.0 mmol\/L (54 mg\/dL) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"40","author":"International Hypoglycaemia Study Group","year":"2017","journal-title":"Diabetes Care"},{"issue":"20","key":"10.1016\/j.metabol.2026.156773_bb0100","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.metabol.2026.156773_bb0105","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.soard.2017.01.025","article-title":"Medical nutrition therapy for post-bariatric hypoglycemia: practical insights","volume":"13","author":"Suhl","year":"2017","journal-title":"Surg Obes Relat Dis"},{"issue":"8","key":"10.1016\/j.metabol.2026.156773_bb0110","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jval.2019.02.009","article-title":"United States valuation of EQ-5D-5L health states using an international protocol","volume":"22","author":"Pickard","year":"2019","journal-title":"Value Health"},{"issue":"8","key":"10.1016\/j.metabol.2026.156773_bb0115","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1111\/dom.15096","article-title":"Continuous glucose monitoring in patients with post-bariatric hypoglycaemia reduces hypoglycaemia and glycaemic variability","volume":"25","author":"Cummings","year":"2023","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"10.1016\/j.metabol.2026.156773_bb0120","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15071","article-title":"Effectiveness of educational and behavioural interventions for reducing fear of hypoglycaemia among adults with type 1 diabetes: systematic review and meta-analyses","volume":"40","author":"Chatwin","year":"2023","journal-title":"Diabet Med"},{"issue":"4","key":"10.1016\/j.metabol.2026.156773_bb0125","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2337\/dc10-1343","article-title":"Psychometric properties of the Hypoglycemia Fear Survey-II for adults with type 1 diabetes","volume":"34","author":"Gonder-Frederick","year":"2011","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.metabol.2026.156773_bb0130","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1007\/s12325-019-01101-6","article-title":"Subcutaneous injection of drugs: literature review of factors influencing pain sensation at the injection site","volume":"36","author":"Usach","year":"2019","journal-title":"Adv Ther"},{"key":"10.1016\/j.metabol.2026.156773_bb0135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.appet.2014.07.009","article-title":"Initial evidence that GLP-1 receptor blockade fails to suppress postprandial satiety or promote food intake in humans","volume":"82","author":"Melhorn","year":"2014","journal-title":"Appetite"},{"issue":"9","key":"10.1016\/j.metabol.2026.156773_bb0140","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1089\/met.2020.0049","article-title":"A pilot study examining the effects of GLP-1 receptor blockade using exendin-(9,39) on gastric emptying and caloric intake in subjects with and without bariatric surgery","volume":"18","author":"Kittah","year":"2020","journal-title":"Metab Syndr Relat Disord"},{"issue":"24","key":"10.1016\/j.metabol.2026.156773_bb0145","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.metabol.2026.156773_bb0150","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.2337\/db13-0468","article-title":"Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk","volume":"63","author":"Chow","year":"2014","journal-title":"Diabetes"},{"issue":"15","key":"10.1016\/j.metabol.2026.156773_bb0155","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1056\/NEJMoa1003795","article-title":"Severe hypoglycemia and risks of vascular events and death","volume":"363","author":"Zoungas","year":"2010","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.metabol.2026.156773_bb0160","article-title":"Population PK (PopPK) and pharmacokinetic\/pharmacodynamic (PK\/PD) analysis of avexitide in individuals with post-bariatric hypoglycemia [abstract SAT-559]","volume":"9","author":"Craig","year":"2025","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.metabol.2026.156773_bb0165","series-title":"Avexitide for treatment of post-bariatric hypoglycemia (LUCIDITY)","author":"Amylyx Pharmaceuticals Inc.","year":"2026"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526002866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049526002866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:36:43Z","timestamp":1791520603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049526002866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":33,"alternative-id":["S0026049526002866"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156773","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of avexitide for treatment of hypoglycemia following bariatric and other upper gastrointestinal surgeries: a phase 2b study","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2026.156773","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"156773"}}